MRK · Merck GP
last $147.91-0.08%volume $14.19Mmarket cap n/afeed alpacaas of 2026-09-25 15:32
one year · daily closes52-week high $156.4452-week low $77.5901m -5.4%3m +18.0%1y +85.9%
FA · financials · Merck & Co., Inc. from the company's own filingsEDGAR ↗
| quarter ending | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| revenue | $16.61B | $16.29B | $16.40B | $17.28B | $15.81B | $15.53B | $15.62B | $16.66B |
| net income | $-1.33B | $-4.24B | $2.96B | $5.79B | $4.43B | $5.08B | $3.74B | $3.16B |
| EPS (diluted) | -0.54 | -1.72 | 1.20 | 2.32 | 1.76 | 2.01 | 1.48 | 1.24 |
| operating cash flow | $5.37B | $3.92B | $2.86B | $7.82B | $3.29B | $2.50B | $3.45B | $9.29B |
total assets $129.80B (2026-06-30)cash $6.85B (2026-06-30)long term debt $51.08B (2026-06-30)equity $41.93B (2026-06-30)shares outstanding 2,467,171,638 (2026-07-31)
quarterly figures as filed (10-Q / 10-K); where a company reports year-to-date, the quarter is the difference. No estimates.
news · MRKmore →
no matching headlines in the last hours